Search results
Research Analysts Set Expectations for Adverum Biotechnologies, Inc.’s Q1 2024 Earnings...
ETF DAILY NEWS· 2 days agoAdverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for Adverum Biotechnologies in a note ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 4 days agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization
Space-Made Fibers and Novel Biotech Among Research Returning to Earth After Successful Space Station...
NBC 10 - FOX 14 Monroe· 5 days agoResearch on a novel vision loss therapy and space-manufactured optical fibers were among the nearly 565 pounds of science and technology payloads sponsored by the International Space Station ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoIn time for Vision Health Month this May, the Canadian Ophthalmological Society, the national authority on eye and vision care in Canada, has released a new survey to assess Canadians' awareness ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today
Australian project to 'print' a fix for faulty eye and brain cells
Cosmos· 7 days ago“Imagine a world that we could simply ‘print’ neurological diseases out of existence using bio inks and cheap desktop printers.” Well hello future, or at least one that Matthew Griffith, a biophysicist ...
Kodiak Sciences Inc. (NASDAQ:KOD) Given Average Rating of “Reduce” by Analysts
ETF DAILY NEWS· 5 days agoKodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) has been assigned an average rating of “Reduce” from the seven brokerages that are currently covering the stock, Marketbeat reports. Three ...
Sigma Planning Corp Reduces Stake in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 7 days agoSigma Planning Corp lowered its position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Mizuho Lowers Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $52.00
ETF DAILY NEWS· 5 days agoApellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price cut by analysts at Mizuho from $60.00 to $52.00 in a report released on Monday, Benzinga reports. Mizuho’s target ...
